Caliber Imaging & Diagnostics, Inc. (OTCBB: LCDX) is a medical technologies company that designs, develops and markets innovative imaging solutions that shows tissue at the cellular level. The company’s imaging technology platform, Vivascope®, enables researchers and clinicians the ability to view and analyze without a biopsy. U.S. FDA 510(k) cleared, VivaScope has regulatory approval in most major markets. VivaScope also has significant applications in testing and analysis in the cosmetics industry. For more information, visit the company’s website at www.caliberid.com